Patient cohort study for inflammatory myositis
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study is creating a group of patients with idiopathic inflammatory myositis (a condition where your immune system attacks your muscles) to better understand the disease and improve care. It's open to adults ages 18 to 75 who have been diagnosed using specific medical guidelines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You must have a diagnosis of idiopathic inflammatory myositis (a type of muscle inflammation) based on specific medical criteria.
- You must not have another connective tissue disease (like lupus or rheumatoid arthritis).
- Your myositis antibody test must be positive (a negative test means you cannot join).
- You must not have an active infection or a history of active tuberculosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults who may have an autoimmune (self-immune) muscle disease. It aims to better understand and evaluate this condition, which may help guide future diagnosis and care.
This trial is testing an experimental drug for safety in people with certain autoimmune diseases—like myositis, scleroderma, or Sjögren's disease—as well as in healthy volunteers. It aims to find out if the drug is safe enough to study further.
This trial looks at treatment strategies for people with idiopathic inflammatory myopathies, which are illnesses where the immune system attacks muscles. It may help improve how treatment is chosen and optimized for this group of conditions, but it specifically excludes several related muscle diseases.
This trial tests if nerandomilast helps people with active inflammatory muscle disease (myositis) by reducing muscle inflammation and damage. It is for adults who are already on standard treatment for their condition but still have moderate to severe symptoms.
This study follows adults who have (or are being evaluated for) inflammatory muscle conditions to collect health data and genetic test information. It may help researchers better understand these diseases and improve future care.
This research study helps doctors better understand myositis—a group of rare diseases that cause muscle inflammation and weakness. Researchers collect blood samples, medical history, and sometimes muscle biopsies to learn more about what causes these conditions and how to treat them better.
Hear when a new Idiopathic Inflammatory Myopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.